Skip to Content

Kank-A Mouth Pain

Medically reviewed on April 12, 2018.

Dosage form: liquid
Ingredients: Benzocaine 200mg in 1mL
Labeler: Blistex Inc.
NDC Code: 10157-9477

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Kank-A®
Mouth Pain Liquid

Drug Facts

Active ingredient

Benzocaine 20.0% (w/w)

Purpose

Oral anesthetic/analgesic

Uses
  • for the temporary relief of pain due to canker sores, minor irritation of the mouth and gums caused by dentures or orthodontic appliances, or minor injury of the mouth or gums

Warnings

For oral use only

Allergy alert

do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine, or other "caine" anesthetics.

When using this product
  • do not use this product for more than 7 days unless directed by a dentist or doctor. If sore mouth symptoms do not improve in 7 days; if irritation, pain, or redness persists or worsens; or if swelling, rash or fever develops, see your doctor or dentist promptly.
  • do not exceed recommended dosage.

Keep out of reach of children. If more than used for pain is accidentally swallowed, get medical help or contact a Poison Control Center right away.

Directions
  • to assure formation of a long-lasting film coating, dry affected area and apply medication undiluted with applicator
  • allow a few seconds for coating to form
  • use up to 4 times daily, or as directed by a dentist or doctor
  • children under 12 years of age should be supervised in the use of this product
    • children under 2 years of age: consult a dentist or doctor

Other information
  • do not purchase if package has been opened
  • cap tightly after use to avoid evaporation
  • avoid contact with the eyes
  • avoid contact with clothing and household/ furniture surfaces to prevent possible staining
  • this is a personal care item, and should be used by one individual only

Inactive ingredients

benzyl alcohol, cetylpyridinium chloride, compound benzoin tincture, dimethyl isosorbide, ethylcellulose, flavor, octylacrylamide/acrylates/butylaminoethyl methacrylate copolymer, oleth-10, PEG-6, propylene glycol, ricinus communis (castor) seed oil, SD alcohol 38B (29.6% v/v), sodium saccharin, sucralose, tannic acid

PRINCIPAL DISPLAY PANEL - 9.75 mL Bottle Package

NDC 10157-9477-1

PROFESSIONAL
STRENGTH

Blistex®

KANK-A®
Mouth Pain Liquid
ORAL ANESTHETIC

SAVE
$100
NOW
See Inside Back Panel

Maximum Pain Relief

Forms Protective Coating

For Sores Inside the Mouth

 
Canker Sores
 
Denture Abrasions
 
Brace Irritation

ADA
Accepted
American
Dental
Association
®

CONVENIENT
CONTROL-TIP
APPLICATOR

.33 FL OZ (9.75 mL)

KANK-A   MOUTH PAIN
benzocaine liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10157-9477
Route of AdministrationBUCCALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Benzocaine (Benzocaine) Benzocaine200 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZYL ALCOHOL 
CETYLPYRIDINIUM CHLORIDE 
DIMETHYL ISOSORBIDE 
ETHYLCELLULOSES 
OLETH-10 
POLYETHYLENE GLYCOL 300 
PROPYLENE GLYCOL 
CASTOR OIL 
SACCHARIN SODIUM 
SUCRALOSE 
TANNIC ACID 
Product Characteristics
ColorORANGEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:10157-9477-19.75 mL in 1 BOTTLE, WITH APPLICATOR
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34612/01/2011
Labeler - Blistex Inc. (005126354)
Establishment
NameAddressID/FEIOperations
Blistex Inc.005126354MANUFACTURE(10157-9477)

 
Blistex Inc.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide